These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10848652)

  • 21. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
    Inamori M; Togawa J; Iwasaki T; Ozawa Y; Kikuchi T; Muramatsu K; Chiguchi G; Matsumoto S; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Shimamura T; Kubota K; Sakaguchi T; Saito S; Ueno N; Nakajima A
    J Gastroenterol; 2005 May; 40(5):453-8. PubMed ID: 15942709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease.
    Robinson M; Maton PN; Rodriguez S; Greenwood B; Humphries TJ
    Aliment Pharmacol Ther; 1997 Oct; 11(5):973-80. PubMed ID: 9354209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection.
    Kihira K; Satoh K; Saifuku K; Kawakami S; Fukazawa K; Ishino Y; Kimura K; Sugano K
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1083-7. PubMed ID: 10930904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
    Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
    J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
    Ciociola AA; Webb DD; Heath A; Walsh JH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study.
    Vo L; Simonian HP; Doma S; Fisher RS; Parkman HP
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1321-30. PubMed ID: 15932362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
    Cammarota G; Cianci R; Cannizzaro O; Cuoco L; Pirozzi G; Gasbarrini A; Armuzzi A; Zocco MA; Santarelli L; Arancio F; Gasbarrini G
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1339-43. PubMed ID: 11012480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated acidity and rabeprazole pharmacology.
    Gardner JD; Perdomo C; Sloan S; Hahne WF; Barth JA; Rodriguez-Stanley S; Robinson M
    Aliment Pharmacol Ther; 2002 Mar; 16(3):455-64. PubMed ID: 11876698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
    Pantoflickova D; Dorta G; Ravic M; Jornod P; Blum AL
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1507-14. PubMed ID: 12823153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression.
    Shimatani T; Inoue M; Kuroiwa T; Horikawa Y
    Aliment Pharmacol Ther; 2004 Jan; 19(1):113-22. PubMed ID: 14687173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
    Sharara AI
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.
    Hirschowitz BI; Simmons J; Mohnen J
    Aliment Pharmacol Ther; 2002 Feb; 16(2):303-13. PubMed ID: 11860414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status.
    Sugimoto M; Furuta T; Shirai N; Kajimura M; Hishida A; Sakurai M; Ohashi K; Ishizaki T
    Clin Pharmacol Ther; 2004 Oct; 76(4):290-301. PubMed ID: 15470328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.
    Sharara AI; Chaar HF; Racoubian E; Moukhachen O; Barada KA; Mourad FH; Araj GF
    Helicobacter; 2004 Jun; 9(3):255-61. PubMed ID: 15165262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers.
    Wilder-Smith CH; Röhss K; Nilsson-Pieschl C; Junghard O; Nyman L
    Digestion; 2003; 68(4):184-8. PubMed ID: 14691345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acid-suppressive effects of rabeprazole: comparing 10mg and 20mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers.
    Shimatani T; Moriwaki M; Xu J; Tazuma S; Inoue M
    Dig Liver Dis; 2006 Nov; 38(11):802-8. PubMed ID: 16843075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P; Katz PO; Chen Y; Sostek M
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rabeprazole (E3810), a novel proton pump inhibitor, on intragastric pH in healthy volunteers.
    Hongo M; Kimpara T; Moriyama S; Ohara S; Sone S; Tamura T; Asaki S; Toyota T
    Tohoku J Exp Med; 1998 Sep; 186(1):43-50. PubMed ID: 9915106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.